GlaxoSmithKline Sets Up R&D Outpost In San Diego To Oversee West Coast Opportunities

The British multinational pharmaceutical giant GlaxoSmithKline (NYSE: GSK) is establishing an R&D outpost in San Diego to help manage its relationships with venture capital firms, and to prospect along the West Coast for new opportunities in drugs, biologics, vaccines, and other products. It will be GSK’s first office in San Diego, according to Damien McDevitt, a GSK vice president for business development in R&D drug development, who has been overseeing the initiative. He will head the new West Coast hub here.

Help employers find you! Check out all the jobs and post your resume.